ECSP045350A - 5- {2-HIDROXI-3-1- (3-TRIFLUOROMETILFENIL) -CICLOPROPIL-PROPIONILAMINO} -FALIDA AND COMPOUNDS RELATED TO MODULATOR ACTIVITY OF THE PROGESTERONE RECEPTOR TO BE EMPLOYED IN THE CONTRACEPTION AND IN A HORMAL REPLACEMENT THERAPY - Google Patents

5- {2-HIDROXI-3-1- (3-TRIFLUOROMETILFENIL) -CICLOPROPIL-PROPIONILAMINO} -FALIDA AND COMPOUNDS RELATED TO MODULATOR ACTIVITY OF THE PROGESTERONE RECEPTOR TO BE EMPLOYED IN THE CONTRACEPTION AND IN A HORMAL REPLACEMENT THERAPY

Info

Publication number
ECSP045350A
ECSP045350A ECSP045350A ECSP045350A EC SP045350 A ECSP045350 A EC SP045350A EC SP045350 A ECSP045350 A EC SP045350A EC SP045350 A ECSP045350 A EC SP045350A
Authority
EC
Ecuador
Prior art keywords
progesterone receptor
contraception
trifluorometilfenil
propionilamino
falida
Prior art date
Application number
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP045350 priority Critical patent/ECSP045350A/en
Publication of ECSP045350A publication Critical patent/ECSP045350A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención consiste en progestinas no esteroides de la fórmula general (I) donde R1 y R2 son, independientemente entre sí, -H o -F, R3 es -CH3 o -CF3, y Ar es (a) o (b), o un derivado o análogo del mismo aceptable para uso farmacéutico. Estas progestinas son adecuadas para modular selectivamente los efectos mediados por el receptor de progesterona en diferentes tejidos de interés, en particular en tejidos de útero versus tejido de mama. Por ello, las progestinas de la presente invención, optativamente en combinación con estrógenos, se pueden utilizar en la contracepción (en particular en los anticonceptivos orales libres de estrógenos), para reemplazo hormonal y para trastornos ginecológicos. La presente invención se relaciona además con una forma de modular selectivamente los efectos mediados por el receptor de progesterona en diferentes tejidos u órganos de interés.The present invention consists of non-steroidal progestins of the general formula (I) where R1 and R2 are, independently of each other, -H or -F, R3 is -CH3 or -CF3, and Ar is (a) or (b), or a derivative or analog thereof acceptable for pharmaceutical use. These progestins are suitable for selectively modulating the effects mediated by the progesterone receptor in different tissues of interest, in particular in uterine tissues versus breast tissue. Therefore, the progestins of the present invention, optionally in combination with estrogens, can be used in contraception (in particular in estrogen-free oral contraceptives), for hormonal replacement and for gynecological disorders. The present invention also relates to a way of selectively modulating the effects mediated by the progesterone receptor in different tissues or organs of interest.

ECSP045350 2004-10-08 2004-10-08 5- {2-HIDROXI-3-1- (3-TRIFLUOROMETILFENIL) -CICLOPROPIL-PROPIONILAMINO} -FALIDA AND COMPOUNDS RELATED TO MODULATOR ACTIVITY OF THE PROGESTERONE RECEPTOR TO BE EMPLOYED IN THE CONTRACEPTION AND IN A HORMAL REPLACEMENT THERAPY ECSP045350A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP045350 ECSP045350A (en) 2004-10-08 2004-10-08 5- {2-HIDROXI-3-1- (3-TRIFLUOROMETILFENIL) -CICLOPROPIL-PROPIONILAMINO} -FALIDA AND COMPOUNDS RELATED TO MODULATOR ACTIVITY OF THE PROGESTERONE RECEPTOR TO BE EMPLOYED IN THE CONTRACEPTION AND IN A HORMAL REPLACEMENT THERAPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP045350 ECSP045350A (en) 2004-10-08 2004-10-08 5- {2-HIDROXI-3-1- (3-TRIFLUOROMETILFENIL) -CICLOPROPIL-PROPIONILAMINO} -FALIDA AND COMPOUNDS RELATED TO MODULATOR ACTIVITY OF THE PROGESTERONE RECEPTOR TO BE EMPLOYED IN THE CONTRACEPTION AND IN A HORMAL REPLACEMENT THERAPY

Publications (1)

Publication Number Publication Date
ECSP045350A true ECSP045350A (en) 2004-11-26

Family

ID=40419306

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP045350 ECSP045350A (en) 2004-10-08 2004-10-08 5- {2-HIDROXI-3-1- (3-TRIFLUOROMETILFENIL) -CICLOPROPIL-PROPIONILAMINO} -FALIDA AND COMPOUNDS RELATED TO MODULATOR ACTIVITY OF THE PROGESTERONE RECEPTOR TO BE EMPLOYED IN THE CONTRACEPTION AND IN A HORMAL REPLACEMENT THERAPY

Country Status (1)

Country Link
EC (1) ECSP045350A (en)

Similar Documents

Publication Publication Date Title
CR7490A (en) 5- (2-HIDROXI-3-1- (3-TRIFLUOROMETILFENIL) -CICLOPROPIL-PROPIONILAMINO) -FALIDA AND COMPOUNDS RELATED TO MODULATOR ACTIVITY OF THE PROGESTERONE RECEPTOR TO BE EMPLOYED IN CONTRACEPTION AND IN A HORMAL REPLACEMENT THERAPY
US20230142627A1 (en) Pharmaceutical compositions and methods
ES2325916T3 (en) ANTIANGIOGENIC ACTIVITY OF TALIDOMIDE ANALOGS REPLACED WITH NITROGEN.
DK1768625T3 (en) Sustained release compositions containing progesterone receptor modulators
AR057060A1 (en) TANAPROGET COMPOSITIONS CONTAINING ETHYL ESTRADIOL
AR035828A1 (en) CHANNEL OPENER K ACTIVATED BY CALCIUM OF GREAT CONDUCTANCE, USE OF THE SAME OR A SUBSTITUTED AZOL COMPOUND TO PREPARE A MEDICINAL PRODUCT, SUBSTITUTED AZOL COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A MEDICINAL PRODUCT
ECSP056095A (en) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE RELIABLE OBTAINING OF ACCEPTABLE LEVELS OF TESTOSTERONE IN SERUM
CR8207A (en) AN ANCIENT- SPECIFIC CA6 CYTOTOXIC CONJUGATE AND METHODS TO USE THE SAME
UY27023A1 (en) FENYL KETON DERIVATIVES REPLACED AS IP ANTAGONISTS
AR061101A1 (en) FENIL-TRIAZOLIL- METOXI-ARILO COMPOSITE, ITS USE FOR THE MANUFACTURE OF A PHARMACEUTICAL MEDICINAL COMPOSITION AND COMPOSITION
JP2008509216A (en) Progesterone receptor modulators containing pyrrole-oxindole derivatives and uses thereof
ECSP066459A (en) MIMETICS OF GLUCOCORTICOIDS, PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME
NO20024908L (en) 8 <beta> -hydrocarbyl-substituted estrogens for use as selective estrogens
SV2002000618A (en) DERIVATIVES OF PIRAZOL REF. PC10769 / 700007 / BB
HRP20171805T1 (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases
PE20070344A1 (en) REGIMES FOR THE ADMINISTRATION OF THE DOSAGE UNITS OF SINGLE-PHASE ORAL CONTRACEPTIVES
AR032138A1 (en) DERIVATIVES OF 6-HYDROXY-INDAZOL, AN OPHTHALMIC COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF GLAUCOMA
UY29245A1 (en) MEDICAL COMBINATIONS
UY29244A1 (en) MEDICAL COMBINATIONS
UY29802A1 (en) ANALOGS OF PHENYLETHYLAMINE AND ITS USE IN THE TREATMENT OF GLAUCOMA
AR049405A1 (en) DICETOPIPERAZINE COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, USE OF THE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCEDURE FOR THE PREPARATION OF THE SAME
ECSP045350A (en) 5- {2-HIDROXI-3-1- (3-TRIFLUOROMETILFENIL) -CICLOPROPIL-PROPIONILAMINO} -FALIDA AND COMPOUNDS RELATED TO MODULATOR ACTIVITY OF THE PROGESTERONE RECEPTOR TO BE EMPLOYED IN THE CONTRACEPTION AND IN A HORMAL REPLACEMENT THERAPY
CR9627A (en) CYANOPYRROLE-SULFONAMIDE PROGESTERONE RECEPTOR MODULATORS AND USES THEREOF
CL2004000779A1 (en) COMPOUNDS DERIVED FROM 3-AZABICICLO [3.2.1] OCTANO, PHARMACEUTICAL COMPOSITION, PREPARATION PROCEDURE, USEFUL TO PREPARE MEDICATIONS TO TREAT IRRITABLE INTESTINE SYNDROME, RELEASE, NAUSEAS, VOMITES, SEXUAL DYSFUNCTION, ALZHE
UY29823A1 (en) SUBSTITUTED DERIVATIVES OF 7-CHLORINE-3H-IMIDAZOL- (4,5-B) PIRIDINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THE PREPARATION OF THE SAME AND APPLICATIONS